SIEGYSIEGY
US • —
$160.91
P/E
16.43
PEG
—
FCF Yield
—
Rev Growth YoY
+2.4% YoY
Gross Margin
38.8%
Health Score
6/10
D/E Ratio
0.90
Confidence
MEDIUM
Business Snapshot
SIEGY (Siemens AG) is a global industrial conglomerate operating across electrification, automation, digitalization, transportation, and healthcare technology through its Siemens Healthineers subsidiary. It competes in diverse end-markets including factory automation, power generation, rail infrastructure, and medical imaging, holding leading positions in industrial software and building technologies. With a market cap placing it firmly in large-cap territory, the company derives significant scale from its multi-segment structure. The defining characteristic is its deeply diversified portfolio spanning physical and digital industrial infrastructure, providing revenue stability across varying economic cycles.
Financial Health
Gross margin stands at 38.8% versus the previous year's figure of N/A, while net margin is 9.7% — both suggesting a stable but not expanding profitability profile. The balance sheet is healthy but not fortress-like, with a manageable debt/equity ratio of 0.9x and a current ratio of 1.37x, indicating sufficient near-term liquidity coverage...
Risk Assessment
- EARNINGS QUALITY — Only 2 out of the last 4 quarters beat analyst estimates, indicating a mixed earnings track record and average management forecasting credibility.
- EARNINGS DECLINE — Earnings contracted by 20.7% year-over-year, significantly outpacing modest revenue growth of 2.4%, signaling margin compression or non-recurring charges.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- VALUATION DIVERGENCE — The P/E of 16.43x appears cheap versus the sector 22x, but the inability to calculate a DCF value due to missing FCF data means there is no reliable anchor for intrinsic value....
Gross margin stands at 38.8% versus the previous year's figure of N/A, while net margin is 9.7% — both suggesting a stable but not expanding profitability profile. The balance sheet is healthy but not fortress-like, with a manageable debt/equity ratio of 0.9x and a current ratio of 1.37x, indicating sufficient near-term liquidity coverage. Free cash flow data is unavailable in the payload, preventing an assessment of organic cash generation and dividend coverage capacity. Overall, the company's moderate leverage and adequate current ratio suggest financial flexibility for reinvestment and dividends, though the absence of FCF data limits full confidence.
- EARNINGS QUALITY — Only 2 out of the last 4 quarters beat analyst estimates, indicating a mixed earnings track record and average management forecasting credibility. - EARNINGS DECLINE — Earnings contracted by 20.7% year-over-year, significantly outpacing modest revenue growth of 2.4%, signaling margin compression or non-recurring charges. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - VALUATION DIVERGENCE — The P/E of 16.43x appears cheap versus the sector 22x, but the inability to calculate a DCF value due to missing FCF data means there is no reliable anchor for intrinsic value.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives